|
GGA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.573700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.484200E-02 |
| Normal-vs-Stage2 |
9.577900E-02 |
| Normal-vs-Stage3 |
3.444400E-01 |
| Normal-vs-Stage4 |
2.765400E-01 |
| Stage1-vs-Stage2 |
6.478800E-01 |
| Stage1-vs-Stage3 |
4.064400E-01 |
| Stage1-vs-Stage4 |
8.828600E-01 |
| Stage2-vs-Stage3 |
3.240600E-01 |
| Stage2-vs-Stage4 |
6.557000E-01 |
| Stage3-vs-Stage4 |
6.723200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.006300E-02 |
| Normal-vs-AfricanAmerican |
2.465600E-01 |
| Normal-vs-Asian |
9.287800E-02 |
| Caucasian-vs-AfricanAmerican |
7.453200E-01 |
| Caucasian-vs-Asian |
5.791000E-01 |
| AfricanAmerican-vs-Asian |
9.397000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.337160E-01 |
| Normal-vs-Female |
5.027800E-02 |
| Male-vs-Female |
9.312400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.562300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.111200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.758500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.565760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.359600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.231200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.016190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.693230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.288410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.322000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.987560E-01 |
| Classical-VS-Follicular |
7.889800E-01 |
| Classical-VS-Other |
7.655000E-01 |
| Classical-VS-Normal |
2.952400E-02 |
| Tall-VS-Follicular |
1.872010E-01 |
| Tall-VS-Other |
7.246000E-01 |
| Tall-VS-Normal |
9.749200E-01 |
| Follicular-VS-Other |
7.193800E-01 |
| Follicular-VS-Normal |
6.238300E-02 |
| Other-VS-Normal |
7.940400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.816100E-02 |
| Normal-vs-N1 |
6.343000E-01 |
| N0-vs-N1 |
3.301600E-01 |
|
|
